Saturday, 06 June 2020


Life Signals receives HSA marketing approval for Tripatch in Singapore

16 April 2020 | News

ECG Remote Monitoring Patch Platform (LX1250) allows Healthcare professionals to remotely access data and rapidly make treatment decisions independent of patient location

Continuous patient monitoring with remote data access in ambulatory, hospital and home settings enables faster clinical decision making

Continuous patient monitoring with remote data access in ambulatory, hospital and home settings enables faster clinical decision making

 

US based LifeSignals Inc., has announced marketing approval for the Tripatch* ECG Remote Monitoring Patch Platform in Singapore from the Health Sciences Authority (HSA), a statutory body under the Ministry of Health of the Singapore Government.

Tripatch is a wireless remote monitoring system intended for use by healthcare professionals for continuous collection of Electrocardiography (ECG) and Heart Rate monitoring in ambulatory, hospital and healthcare settings. Patient data can be transmitted throughout the care continuum wirelessly with ultra-high reliability from the Tripatch Biosensor Patch to cloud-based platforms for storage and analysis. Healthcare professionals can then remotely access this data and rapidly make treatment decisions independent of patient location.

According to Ministry of Health figures, almost one out of three deaths in Singapore is caused by heart diseases or stroke. Welcoming the HSA approval, Surendar Magar, co-founder and CEO of LifeSignals said: “We believe Tripatch can make a major contribution to cardiovascular care in Singapore. For the first time a patient’s clinical data can be captured seamlessly from any setting - hospital, ambulatory or home – and securely transmitted wirelessly to existing medical monitoring systems in current hospitals or new cloud-based systems for analysis. By “untethering” the patient, healthcare professionals can make faster treatment decisions, while patients can be confident of receiving data-driven, personalized therapy.”

Tripatch has been developed with a number of enhanced features:

  • 2-channel ECG to ensure optimal data integrity
  • 3-day data capture and heart rate analysis for enhanced diagnosis
  • Single-Use, ‘Fit &Forget’ disposable device for improved patient compliance and reduced risk of cross-infection.
  • Adaptable to many clinical workflows, including Remote Patient Monitoring system, Mobile Cardiac Telemetry system, Event Monitoring &Holter. 

Tri-Patch will be marketed in Singapore and SE Asia through a network of distributors.

 *Marketed in other territories as M-Patch, 1A Patch.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account